General American Investors CO Inc Gilead Sciences, Inc. Transaction History

General American Investors CO Inc

$1.43 Billion
Q2 2024

A detailed history of General American Investors CO Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, General American Investors CO Inc holds 119,900 shares of GILD stock, worth $10.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

119,900

Previous 119,900 -0.0%

Holding current value

$10.6 Million

Previous $8.78 Million 6.33%

% of portfolio

0.58%

Previous 0.63%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $1.32 Million - $1.9 Million	-21,200 Reduced 15.02%	119,900 $10.3 Million
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $2.32 Million - $2.9 Million	40,000 Added 39.56%	141,100 $8.39 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $12,976 - $14,728	200 Added 0.2%	101,100 $7.34 Million
Q1 2021 May 03, 2021	BUY	$60.0 - $68.46 $1.56 Million - $1.78 Million	26,000 Added 34.71%	100,900 $6.52 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $2.83 Million - $3.23 Million	50,000 Added 200.8%	74,900 $4.36 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $4.39 Million - $5.1 Million	-60,700 Reduced 70.91%	24,900 $1.92 Million
Q1 2020 May 01, 2020	SELL	$62.63 - $80.22 $15.5 Million - $19.9 Million	-248,000 Reduced 74.34%	85,600 $6.4 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $2.42 Million - $3.16 Million	-40,000 Reduced 10.71%	333,600 $20.9 Million
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $4.99 Million - $5.52 Million	-70,000 Reduced 15.78%	373,600 $28.8 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $1.42 Million - $1.67 Million	-20,000 Reduced 4.31%	443,600 $31.8 Million
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $33.4 Million - $39.6 Million	463,600	463,600 $37.6 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.

Account

General American Investors CO Inc Gilead Sciences, Inc. Transaction History